Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
about
Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathyDiabetic retinopathy: current management and experimental therapeutic targets.The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A.Epidemiology of diabetic retinopathy and macular oedema: a systematic review.Efficient delivery of NF-κB siRNA to human retinal pigment epithelial cells with hyperbranched cationic polysaccharide derivative-based nanoparticlesBiochemical pathways for microvascular complications of diabetes mellitus.Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathyEmerging drugs for age-related macular degeneration.Pathogenesis and classification of proliferative diabetic vitreoretinopathy.Vascular endothelial growth factor in eye disease.Role of endothelium in vasomotor responses to endothelin system and protein kinase C activation in porcine retinal arteriolesMultifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes.Protein kinase C inhibitors: a patent review (2010 - present).Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH.Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.Protein kinase C isozymes and their selectivity towards ruboxistaurin.Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism.
P2860
Q27021701-076C822D-CFF7-43BF-A12F-35AC718EDBABQ33403016-5E2D3FE1-6EE1-46A8-B5F2-11C7D7CD9E7AQ34302668-945D1EAD-EA3A-47D0-93C2-539FA87AD515Q34330907-CC882D4B-F17A-4640-AB1B-9F637591526CQ35411181-D50E1F18-F752-4429-A477-508D250B3D83Q35590990-D79F64CB-82F1-4B25-B30E-3156D48253E8Q35739660-2F5C2A1C-F529-4A4B-87FD-AF704514B787Q35770186-284ED685-F5CE-490C-8C89-C436BC5107EDQ36256287-D196FAF3-756A-4000-832C-FF4AB1E8D32DQ36468930-E961D826-57E5-4875-BD8D-DB5F6A029CC2Q36634283-10D05248-A51F-4172-8AA8-55FDF994A8A0Q36767464-7904E311-7297-4C12-8FEA-ED5E4FBB5935Q36929380-12DE1E44-7A16-40B3-B25E-0D786269147CQ37328871-9D7E9571-488E-4D8B-9A43-6CD0BCB317EEQ37431709-230FD667-C117-460E-AEE6-CF9F2B17C300Q38116565-E4C67E22-674F-42CF-A5B7-240E21ADFDD9Q38463463-FADFCF48-02F0-450A-90B9-F77FD13A96CAQ40137753-3C98850D-691C-42FA-AE63-A59139326CEBQ44982994-7812BA89-CC4D-4BB2-B302-E578DE137692Q46794973-0189B514-2DB5-4D56-9D57-EF212EE70974Q53766666-BEC114E5-D2DF-4D83-9552-AE4407356722
P2860
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@ast
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@en
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@nl
type
label
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@ast
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@en
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@nl
prefLabel
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@ast
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@en
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@nl
P1476
Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
@en
P2093
Robert N Frank
P304
P356
10.1016/S0002-9394(02)01321-1
P407
P577
2002-05-01T00:00:00Z